Clinical trial MCLA-158-CL01
Phase 1 dose escalation and cohort expansion study evaluating single-agent MCLA-158 in metastatic colorectal cancer and other advanced solid tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Merus |
| EudraCT Identifier | 2017-004745-24 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03526835 |
| Inclusion criteria | Metastatic Biopsy mandatory |
| Last update |